Krishna Institute of Medical Sciences is currently trading at Rs. 558.40, up by 1.90 points or 0.34% from its previous closing of Rs. 556.50 on the BSE.
The scrip opened at Rs. 550.70 and has touched a high and low of Rs. 561.55 and Rs. 546.10 respectively. So far 16100 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 603.95 on 11-Nov-2024 and a 52 week low of Rs. 350.02 on 04-Jun-2024.
Last one week high and low of the scrip stood at Rs. 603.95 and Rs. 546.10 respectively. The current market cap of the company is Rs. 22087.67 crore.
The promoters holding in the company stood at 38.82%, while Institutions and Non-Institutions held 48.15% and 13.03% respectively.
Krishna Institute of Medical Sciences (KIMS) has entered into an Operations and Management Agreement with Insignia Healthcare for initial term of 15 years with an extension for a further period of 10 years to operate, manage and to provide healthcare medical services to a newly constructed super specialty hospital having around 150 bed capacity at Guntur-Andhra Pradesh.
The Super Specialty Hospital will be under the exclusive supervision and control of KIMS, and shall be branded as ‘KIMS-SIKHARA’. KIMS shall be solely responsible for its operation and efficient management.
Krishna Institute of Medical Sciences offers a comprehensive range of healthcare services including oncology, cardiac sciences, neurosciences, gastric sciences, orthopaedics, renal sciences, organ transplantation, and mother & child care.
| Company Name | CMP |
|---|---|
| Apollo Hospital Ent. | 7756.50 |
| Max Healthcare Inst | 1015.70 |
| Narayana Hrudayalay | 1839.80 |
| Aster DM Healthcare | 731.10 |
| Global Health | 1181.45 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: